Sangamo Therapeutics Inc
SGMO
$0.07+0.00%
Delayed · as of Aug 25, 2026, 11:38 AM ET
Mkt cap
$74.57M
EV/Sales
1.36
P/E ratio
N/A
FY2025 Revenue
$39.55M
EPS (FY2025)
N/A
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-310.81%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Sangamo Therapeutics Inc (SGMO) is a biotechnology company listed on NASDAQ.
Latest reported SGMO revenue for 2025-12-31 was $39.6M. Net income was -$122.9M. Revenue was down 31.6% from 2024-12-31 to 2025-12-31. SGMO currently screens at market cap $74.6M.
Use this SGMO research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full SGMO income, balance, and cash tables.
Sangamo Therapeutics Inc (SGMO) is a biotechnology company in the Healthcare sector.
Latest cached Sangamo Therapeutics Inc (SGMO) revenue for Dec 31, 2025 was $39.6M. Net income was -$122.9M. Statements: https://lician.com/financials/sgmo
Sangamo Therapeutics Inc (SGMO) market capitalization is $74.6M on the latest cached snapshot.
Sangamo Therapeutics Inc (SGMO) cached previous close $0.07; day range $0.06 – $0.13; volume 28,502,598. Session quote: https://lician.com/quote/sgmo
Sangamo Therapeutics Inc (SGMO) latest cached earnings event is "SGMO earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached SGMO filing is 8-K · Sep 8, 2026. Filings: https://lician.com/sec/sgmo